Drug-releasing implants delivering chemotherapeutic and radio-sensitizing agents are beginning to play a major role in the postsurgical eradication of residual glioma in the brain. Benefits from early arresting of tumor growth and tumor recovery dynamics stress the impact of drug release profiles of
1040 Implantable biodegradable polymers for radiosensitization of human glioma in vivo
✍ Scribed by Jeffery Williams; Larry E. Dillehay; Eric Sipos; Christian Fahlman; Kevin Tabassi; Jerry Williams; Moody Wharam; Henry Brem
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 113 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We are developing a new spinal implant system (SIS) without fusion (bone graft). This SIS is made from two materials, metal and polyetheretherketone (PEEK) polymer. The Food and Drug Administration recommended testing __in vivo,__ in an animal model, whether the PEEK polymer could be us
## Abstract The development of a homemade device for __in vivo__ human determination of the open circuit potential (OCP) of Nitinol is described. Pseudo‐reference electrodes (316L stainless steel and Pt) were initially tested and validated __in vitro__ using simulated body fluids. As judged from th